Sign In

Andy Emba

Visionary seeking to bring about citizen centric health ecosystems

Andy Emba, also known as Andy Bushell on LinkedIn, holds significant roles at Novartis and OoNiDa. He serves as the Early Portfolio Global Program Head at Novartis, where he is responsible for overseeing the development and management of innovative healthcare solutions across various therapeutic areas. His leadership focuses on enhancing patient access to medicines and improving health outcomes globally.

In addition to his role at Novartis, Emba is the President of OoNiDa, an organization dedicated to advancing healthcare initiatives. His work with OoNiDa emphasizes collaboration with various stakeholders to address health challenges, particularly in underserved communities. Emba's commitment to global health improvement is evident through his initiatives, such as the Chronic Disease Foundation, which he co-founded to enhance care coordination for chronic disease patients.

Emba's background includes a strong emphasis on patient-centric approaches and sustainable business practices in healthcare. He has been recognized for his visionary leadership and dedication to making a positive impact on global health challenges, particularly in the context of increasing access to innovative treatments for chronic diseases.

Highlights

Jan 15 · unco.edu
Office of the President - University of Northern Colorado
Sep 9 · orau.org
Andy Page, ORAU President and Chief Executive Officer
2017 Best EMBAs: Andy Bushell, INSEAD - Poets&Quants for Execs

Related Questions

What are Andy Emba's main responsibilities at Novartis?
How did Andy Emba transition from leadership roles in universities to pharmaceuticals?
What initiatives has Andy Emba led at Novartis?
How does Andy Emba's work at OoNiDa contribute to his role at Novartis?
What are some notable achievements of Andy Emba in his career?
Andy Emba
Add to my network

Location

Basel, Basel, Switzerland